70
Participants
Start Date
April 1, 2022
Primary Completion Date
December 30, 2023
Study Completion Date
December 30, 2024
Hippocampal-sparing
Dose constraint placed on hippocampi to minimize dose to hippocampi, while maintaining target coverage (at least 98% of brain metastasis volume must receive 100% of prescription dose).
Stereotactic radiosurgery
Stereotactic radiosurgery (SRS) with prescription dose determined based on size of brain metastasis; 21 or 24 Gy in a single fraction if less than or equal to 20 mm, 18Gy in a single fraction in 21 - 30 mm, 15 Gy in a single fraction or 30 Gy in 5 fractions if 31 - 40 mm (physician discretion).
Lead Sponsor
Ottawa Hospital Research Institute
OTHER